|
ROCK2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.94659999230851E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.24089985351372E-10 |
| Normal-vs-Stage2 |
4.190000E-04 |
| Normal-vs-Stage3 |
3.56440000000013E-05 |
| Normal-vs-Stage4 |
1.220100E-04 |
| Stage1-vs-Stage2 |
7.613200E-01 |
| Stage1-vs-Stage3 |
3.602400E-01 |
| Stage1-vs-Stage4 |
9.477000E-01 |
| Stage2-vs-Stage3 |
6.786800E-01 |
| Stage2-vs-Stage4 |
8.036600E-01 |
| Stage3-vs-Stage4 |
5.100400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.66759994701948E-09 |
| Normal-vs-AfricanAmerican |
1.62149999982653E-07 |
| Normal-vs-Asian |
3.627900E-04 |
| Caucasian-vs-AfricanAmerican |
9.038200E-01 |
| Caucasian-vs-Asian |
6.520200E-01 |
| AfricanAmerican-vs-Asian |
6.402600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.70130576293559E-12 |
| Normal-vs-Female |
1.587660E-02 |
| Male-vs-Female |
2.210100E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.21130000030334E-07 |
| Normal-vs-Extreme_Weight |
2.29740004797918E-10 |
| Normal-vs-Obese |
1.87640999999017E-05 |
| Normal-vs-Extreme_Obese |
3.93870000003904E-06 |
| Normal_Weight-vs-Extreme_Weight |
4.189600E-01 |
| Normal_Weight-vs-Obese |
1.684780E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.219600E-01 |
| Extreme_Weight-vs-Obese |
1.348010E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.679200E-01 |
| Obese-vs-Extreme_Obese |
2.209600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.796570E-01 |
| Normal-vs-Age(41-60Yrs) |
3.85230000010672E-07 |
| Normal-vs-Age(61-80Yrs) |
3.80090403595545E-11 |
| Normal-vs-Age(81-100Yrs) |
8.49969999938693E-08 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.246400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.361780E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.569800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.879650E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.524000E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.174800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.05039976716625E-10 |
| Normal-VS-Type2 PRCC |
1.90729998461592E-09 |
| Normal-VS-KIRP CIMP |
8.233000E-01 |
| Normal-VS-Unclassified PRCC |
1.670340E-02 |
| Type1 PRCC-VS-Type2 PRCC |
9.382400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.795700E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
7.884000E-02 |
| Type2 PRCC-VS-KIRP CIMP |
5.100200E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
9.684300E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.399180E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.35169694618298E-11 |
| Normal-vs-N1 |
9.268000E-02 |
| Normal-vs-N2 |
1.724290E-02 |
| N0-vs-N1 |
1.626200E-02 |
| N0-vs-N2 |
4.198400E-01 |
| N1-vs-N2 |
5.616200E-01 |
|
|
